Form 4: Ultragenyx Director Sanders Sells 1,737 Shares of Common Stock

Director Corazon (Corsee) D. Sanders of Ultragenyx Pharmaceutical Inc. sold 1,737 shares of common stock at a price of $41.1 on June 10, 2024.

Summary

• On June 10, 2024, Corazon (Corsee) D. Sanders, a director of Ultragenyx Pharmaceutical Inc., sold 1,737 shares of common stock.
• The transaction was executed at a price of $41.1 per share.
• Following the transaction, Sanders directly owns 7,248 shares of Ultragenyx common stock, which includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like directors and officers, trade their company's stock. These filings provide transparency into insider transactions, which can be closely watched by investors for signals about the company's prospects.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction.

Key Dates